Comment by SubiculumCode
6 hours ago
My job depends on NIH continuing to function, but it is not immediately clear that this particular decision follows other worrying trends discussed here previously. Removing K-awards for clinical trials (but not regular, cheaper study formats) might simply be a recognition that clinical trials are too expensive for the K-format and conducting underpowered clinical trials does not help anyone much.
might simply be is exactly right, very unlikely… and knowing what you know and have seen since Jan of 2025 you know how slim that “might” is